Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression

Movement Disorders(2020)10.1002/mds.28206Source: DataRank Database

Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression is a research paper published in Movement Disorders (2020). On theSindex it has a DataRank of 0. It has been cited 201 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access201 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (14 grants)Impact (FWCI 9.29)OA: hybridTopics (25)Linked Datasets (10)DataCite Reuse (10)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (26)

Mohammed Dakna ORCID,Niels Kruse ORCID,Douglas Galasko ORCID,Tatiana Foroud ORCID,Henrik Zetterberg ORCID

Live enrichment

PubMed:32798333 PMC:PMC8017468 OpenAlex:https://openalex.org/W3049316820

Medical Research Council

Grant: UKDRI-1003

Intramural NIH HHS

Grant: Z01 AG000949

Avid Radiopharmaceuticals

AbbVie

H. Lundbeck A/S

Genentech

UCB

Michael J. Fox Foundation for Parkinson's Research

Pfizer

Biogen Idec

GE Healthcare

Merck

Bristol-Myers Squibb

GlaxoSmithKline

FWCI

9.29

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28206

publisherhttps://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28206

publisherhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmds.28206

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.28206

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/mds.28206

Fields of Study

Parkinson's Disease Mechanisms and TreatmentsVoice and Speech DisordersNeurological disorders and treatments

MeSH Terms

HumansIntermediate FilamentsParkinson DiseaseCohort StudiesBiomarkersDisease Progression

Keywords

BiomarkerParkinson's diseaseCohortNeurofilamentMedicineNeuroprotectionInternal medicineDiseaseOncologyDegenerative diseasePathologyBiologyImmunohistochemistryCohort studiesOutcome ResearchParkinson's Disease/parkinsonism

Additional file 1 of High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease

10.6084/m9.figshare.16944567.v1figshare

Additional file 1 of High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease

10.6084/m9.figshare.16944567figshare

Additional file 1 of Neurofilament light chain is increased in the parahippocampal cortex and associates with pathological hallmarks in Parkinson’s disease dementia

10.6084/m9.figshare.22608836.v1figshare

Additional file 1 of Neurofilament light chain is increased in the parahippocampal cortex and associates with pathological hallmarks in Parkinson’s disease dementia

10.6084/m9.figshare.22608836figshare

Additional file 2 of Neurofilament light chain is increased in the parahippocampal cortex and associates with pathological hallmarks in Parkinson’s disease dementia

10.6084/m9.figshare.22608839.v1figshare

Additional file 2 of Neurofilament light chain is increased in the parahippocampal cortex and associates with pathological hallmarks in Parkinson’s disease dementia

10.6084/m9.figshare.22608839figshare

Additional file 3 of Neurofilament light chain is increased in the parahippocampal cortex and associates with pathological hallmarks in Parkinson’s disease dementia

10.6084/m9.figshare.22608842.v1figshare

Additional file 3 of Neurofilament light chain is increased in the parahippocampal cortex and associates with pathological hallmarks in Parkinson’s disease dementia

10.6084/m9.figshare.22608842figshare

Additional file 1 of Identifying clinically useful biomarkers in neurodegenerative disease through a collaborative approach: the NeuroToolKit

10.6084/m9.figshare.22613084.v1figshare

Additional file 1 of Identifying clinically useful biomarkers in neurodegenerative disease through a collaborative approach: the NeuroToolKit

10.6084/m9.figshare.22613084figshare